Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 119, Issue 1, Pages 32-40
Publisher
Wiley
Online
2015-12-13
DOI
10.1111/bcpt.12543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis
- (2015) Jun-Jie Chen et al. Scientific Reports
- Spinal NF-κB and Chemokine Ligand 5 Expression during Spinal Glial Cell Activation in a Neuropathic Pain Model
- (2015) Qin Yin et al. PLoS One
- Evidence for Involvement of Spinal RANTES in the Antinociceptive Effects of Triptolide, a Diterpene Triepoxide, in a Rat Model of Bone Cancer Pain
- (2014) Li-Hua Hang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- CCR1 Plays a Critical Role in Modulating Pain through Hematopoietic and Non-Hematopoietic Cells
- (2014) Nuruddeen D. Lewis et al. PLoS One
- Experimental autoimmune prostatitis induces microglial activation in the spinal cord
- (2014) Larry Wong et al. PROSTATE
- Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain
- (2013) Satoshi Imai et al. BRAIN
- Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury
- (2013) Norikazu Kiguchi et al. CYTOKINE
- The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells
- (2013) M. Pevida et al. NEUROSCIENCE
- Chemokines as peripheral pain mediators
- (2013) John M. Dawes et al. NEUROSCIENCE LETTERS
- Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
- (2012) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Absence of C–C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model
- (2012) Jiin-Tarng Liou et al. PAIN
- In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils
- (2011) J. M. Paulsson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain
- (2011) Friederike Knerlich-Lukoschus et al. JOURNAL OF NEUROSURGERY-SPINE
- Toll-Like Receptor 2 Contributes to Chemokine Gene Expression and Macrophage Infiltration in the Dorsal Root Ganglia after Peripheral Nerve Injury
- (2011) Donghoon Kim et al. Molecular Pain
- CC Chemokine Ligand 3 Overcomes the Bacteriocidal and Phagocytic Defect of Macrophages and Hastens Recovery from Experimental Otitis Media in TNF-/- Mice
- (2010) A. Leichtle et al. JOURNAL OF IMMUNOLOGY
- GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
- (2010) N. Eijkelkamp et al. JOURNAL OF NEUROSCIENCE
- CC-chemokine MIP-1α in the spinal cord contributes to nerve injury-induced neuropathic pain
- (2010) Norikazu Kiguchi et al. NEUROSCIENCE LETTERS
- Macrophage inflammatory protein-1α mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1β up-regulation
- (2010) Norikazu Kiguchi et al. PAIN
- Chemokines and pain mechanisms
- (2008) Catherine Abbadie et al. BRAIN RESEARCH REVIEWS
- Chemokines as pain mediators and modulators
- (2008) Fletcher A White et al. Current Opinion in Anesthesiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started